Patients With Pancreatic Cancer Facing Dire Shortages of Essential Digestive Drug

For many patients grappling with pancreatic cancer, each day begins with a stark choice — to eat or to risk malnutrition. The onset of acute shortages of Creon, a crucial pancreatic enzyme replacement therapy (PERT), has forced some patients to restrict themselves to a single meal a day, attempting to ration their dwindling supplies of the medication that allows them to digest food. This distressing situation is compounded for others fighting cystic fibrosis and pancreatitis, who share similar battles.

The Impact of a Widespread Drug Shortage

In a recent survey conducted by the National Pharmacy Association (NPA), 96% of pharmacies across the UK reported difficulties in obtaining adequate stock of Creon. Pharmacists, such as Claire Glastonbury, have described the current situation as “the worst stock shortage” they’ve ever encountered. “It’s heartbreaking to see patients come in looking for help, only to leave empty-handed, often forced to skip meals or take lower doses,” she said.

According to Alfie Bailey-Bearfield, head of influencing and health improvement at Pancreatic Cancer UK, “Thousands of people affected by pancreatic cancer rely on taking PERT tablets every time they eat simply to digest their food and absorb nutrients, something most of us take for granted.” The gravity of this statement is underscored by reports from patients who have resorted to traveling over 30 miles to find pharmacies with even scant supplies available.

Consequences of Missing Medication

Patients who are unable to obtain Creon face severe implications for their health. Without adequate PERT, the body struggles to break down the food consumed, leading to malnutrition, abdominal pain, and significant weight loss. A study published in the Journal of Pancreatic Research found that over 80% of patients with untreated pancreatic insufficiency experienced drastic declines in their quality of life.

• Increased Risk of Surgery Failures: Not taking the proper dosage can render patients ineligible for life-saving surgeries.
• Compromised Chemotherapy Treatment: Many patients find it difficult to endure chemotherapy without proper nutrient absorption.
• Quality of Life Declines: Symptoms like fatigue and weakness can severely impact daily activities.

Why the Shortage? A Look Behind the Curtain

The Department of Health and Social Care (DHSC) cites a Europe-wide shortage linked to a scarcity of raw materials required for manufacturing Creon. This situation has persisted for over a year, leaving thousands of patients vulnerable. Olivier Picard, chair of the NPA, has articulated the sense of unjustness surrounding the situation: “It simply cannot be right that in the 21st century patients are skipping meals to ration their medication.”

The DHSC has extended serious shortage protocols, which allow pharmacists to dispense smaller quantities of the drug, continuing this practice until November 21 of this year. However, this has done little to alleviate the profound distress patients are experiencing as they juggle their health with limited resources.

A Call for Action

Advocates from Pancreatic Cancer UK are urging ministers to take immediate steps to mitigate the impacts of this shortage, including exploring avenues to procure Creon from countries with surplus supplies. The organization warns that without a strategic response, the risk to patient safety remains paramount.

Dr. Rebecca Haynes, a gastroenterologist with over 15 years of experience, emphasizes the urgency of the situation. “These supply shortages put patients in jeopardy. The ramifications extend beyond physical health; they adversely affect mental wellness as well,” she stated.

Patient Perspectives: Real Stories from the Frontline

The plight of patients like 58-year-old Martha Hendricks illustrates the stress caused by this shortage. “I used to enjoy three meals a day, but now I’m down to one. It’s hard to fathom how something so basic to survival is being denied to us,” she shared. Martha, who has always been an active person, now finds it challenging to muster the energy for her daily routine.

Another patient, Oliver Trent, a 45-year-old father from Brighton, commented, “The fear of running out of medication is always looming. I constantly check with pharmacies, but there are no guarantees. My children depend on me, and I can’t afford to be sick.” His words capture a heartbreaking reality for many facing this crisis: the burden feels unmanageable.

Looking Ahead: A System in Crisis

The ongoing Creon crisis invites critical inquiries regarding the healthcare system’s resilience and responsiveness. Experts are demanding urgent reevaluation of existing supply chains and the allocation of resources destined for essential medications. As the NPA puts it, “Medicine shortages not only cause huge inconvenience but can risk serious patient safety issues.”

As long as patients continue to make difficult choices between meals and medication, the ripple effects will be felt throughout families and communities. The conversation must shift from mere acknowledgment of the issue to immediate, actionable solutions. While the medical community works diligently to navigate these choppy waters, those faced with pancreatic cancer, cystic fibrosis, and pancreatitis are left waiting, hoping for a resolution that restores their right to health and basic nutrition.

Source: www.theguardian.com